BioCorteX
3 known investors
BioCorteX develops personalized therapeutics using a microbiome knowledge graph and proprietary biology emulation platform to tailor drug treatments for diverse populations. The company aims to improve treatment efficacy across different communities by accounting for individual microbiome variations in drug development.
AI & Machine LearningBiotechDigital HealthMedical Devices
Founders & leadership
<
<UNKNOWN>CTO & Co-Founder
Investors · 3
In the news
- BioCorteX - Branding for techbio | JDJ Creativejdjcreative.co.uk · 2024
- BioCorteX Raises $5M in Seed Fundingfinsmes.com · 2023
- BioCorteX raises $5 million to unlock drug-bacteria interactions - Tech.eutech.eu · 2023
- BioCorteX - 2026 Company Profile, Team, Funding, Competitors & Financials - Tracxntracxn.com · 2023
- BioCorteX - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2023
- BioCorteX Raises $5 Million in Funding Led by Sofinnova Partners and Hoxton Ventures To Unlock Drug-Bacteria Interactionsfinance.yahoo.com · 2023